TIMP4 and atrial fibrillation: The TIMP4 overexpression and miR-338-3p inhibition did not affect circFryl level (Figures 5A and 6A) but notably recovered TIMP4 expression in sicircFryl-treated fibroblasts (Figures 5B and C) and cardiac tissues from AF model (Figures 6B and C).